Trial intelligence / Profile preview

Efficacy of Oral Tofacitinib vs Oral Prednisolone in Moderate to Severe Alopecia Areata

IRCT20210823052264N12Phase 3Completed

Sponsor
Combined Military Hospital Quetta
Start
Dec 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in alopecia areata comparing Oral tofacitinib with Oral prednisolone (2 arms). Started Dec 2024; status: completed.

02

Drugs

tofacitinibprednisolone
03

Conditions

alopecia areata

Beyond the preview

Go deeper on IRCT20210823052264N12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210823052264N12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call